Abstract
Breast pain, or mastalgia, is one of the most common breast disorders in women. Initial concerns related to the association of breast pain and the risk of breast cancer often prompt patients to seek medical evaluation for breast pain. Mastalgia is further classified as cyclic (associated with the menstrual cycle) and noncyclic. Extramammary pain can often be perceived as mastalgia and awareness of extramammary causes is important in the evaluation of patients presenting with breast pain. The clinical evaluation of mastalgia entails a careful history and physical examination, often with the addition of appropriate imaging studies based upon the type and location of the pain, clinical findings, and age of the patient. A number of non-pharmacologic therapies can be recommended as first-line therapies while reserving pharmacologic treatments for more severe symptoms and complaints. Reassurance can also be an important component in the management of mastalgia, while surgical interventions have a much more limited role.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CM:
-
Cyclic mastalgia
- EP:
-
Extramammary pain
- NCM:
-
Noncyclic mastalgia
References
Leinster SJ, Whitehouse GH, Walsh PV. Cyclical mastalgia: clinical and mammographic observations in a screened population. Br J Surg. 1987;74(3):220–2.
Rosolowich V, Saettler E, Szuck B, Lea RH, Levesque P, Weisberg F, et al. Mastalgia. J Obstet Gynaecol Can. 2006;28(1):49–71; quiz 58–60, 72–4.
Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc. 2004;79(3):353–72.
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341(10):709–17.
Braunstein G. Gynecomastia. In: Harris J, Lippman M, Morrow M, Hellman S, editors. Diseases of the breast. Philadelphia: Lippincott-Raven; 1996. p. 54–60.
Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999;130(8):651–7.
Ader DN, Browne MW. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. Am J Obstet Gynecol. 1997;177(1):126–32.
Davies EL, Gateley CA, Miers M, Mansel RE. The long-term course of mastalgia. J R Soc Med. 1998;91(9):462–4.
Miltenburg DM, Speights Jr VO. Benign breast disease. Obstet Gynecol Clin North Am. 2008;35(2):285–300, ix.
Preece PE, Richards AR, Owen GM, Hughes LE. Mastalgia and total body water. Br Med J. 1975;4(5995):498–500.
Mansel RE. ABC of breast diseases. Breast pain. BMJ. 1994;309(6958):866–8.
Peters F, Diemer P, Mecks O, Behnken LL. Severity of mastalgia in relation to milk duct dilatation. Obstet Gynecol. 2003;101(1):54–60.
Dixon JM. Periductal mastitis/duct ectasia. World J Surg. 1989;13(6):715–20.
Johnson KM, Bradley KA, Bush K, Gardella C, Dobie DJ, Laya MB. Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes. J Gen Intern Med. 2006;21 Suppl 3:S70–5.
Plu-Bureau G, Le MG, Sitruk-Ware R, Thalabard JC. Cyclical mastalgia and breast cancer risk: results of a French cohort study. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1229–31.
Khan SA, Apkarian AV. Mastalgia and breast cancer: a protective association? Cancer Detect Prev. 2002;26(3):192–6 [Erratum in Cancer Detect Prev. 2003;27(1):82].
Olsen ML, Morton M, Stan D, Pruthi S. Is there a role for magnetic resonance imaging in diagnosing palpable breast masses when mammogram and ultrasound are negative? J Womens Health. 2012;21(11):1149–54.
Leung JW, Kornguth PJ, Gotway MB. Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med. 2002;21(5):521–6; quiz 8–9.
Klimberg V. Etiology and management of breast pain. In: Harris J, Lippman M, Morrow M, Hellman S, editors. Diseases of the breast. Philadelphia: Lippincott-Raven; 1996. p. 99–106.
Millet AV, Dirbas FM. Clinical management of breast pain: a review. Obstet Gynecol Surv. 2002;57(7):451–61.
Maddox PR, Mansel RE. Management of breast pain and nodularity. World J Surg. 1989;13(6):699–705.
Gateley CA, Mansel RE. Management of cyclical breast pain. Br J Hosp Med. 1990;43(5):330–2.
BeLieu RM. Mastodynia. Obstet Gynecol Clin North Am. 1994;21(3):461–77.
Hadi MS. Sports brassiere: is it a solution for mastalgia? Breast J. 2000;6(6):407–9.
Mason BR, Page KA, Fallon K. An analysis of movement and discomfort of the female breast during exercise and the effects of breast support in three cases. J Sci Med Sport. 1999;2(2):134–44.
Downey H, Deadman J, Davis C, Leinster S. Psychological characteristics of women with cyclical mastalgia. Breast Dis. 1993;6:99–105.
Fox H, Walker LG, Heys SD, Ah-See AK, Eremin O. Are patients with mastalgia anxious, and does relaxation therapy help? Breast. 1997;6(3):138–42.
Allen SS, Froberg DG. The effect of decreased caffeine consumption on benign proliferative breast disease: a randomized clinical trial. Surgery. 1987;101(6):720–30.
Lubin F, Ron E, Wax Y, Black M, Funaro M, Shitrit A. A case-control study of caffeine and methylxanthines in benign breast disease. JAMA. 1985;253(16):2388–92.
Ferrini RL, Barrett-Connor E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol. 1996;144(7):642–4.
Ernster VL, Mason L, Goodson 3rd WH, Sickles EA, Sacks ST, Selvin S, et al. Effects of caffeine-free diet on benign breast disease: a randomized trial. Surgery. 1982;91(3):263–7.
Parsay S, Olfati F, Nahidi S. Therapeutic effects of vitamin E on cyclic mastalgia. Breast J. 2009;15(5):510–4.
Meyer EC, Sommers DK, Reitz CJ, Mentis H. Vitamin E and benign breast disease. Surgery. 1990;107(5):549–51.
Gateley CA, Maddox PR, Pritchard GA, Sheridan W, Harrison BJ, Pye JK, et al. Plasma fatty acid profiles in benign breast disorders. Br J Surg. 1992;79(5):407–9.
Srivastava A, Mansel RE, Arvind N, Prasad K, Dhar A, Chabra A. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast. 2007;16(5):503–12.
Pruthi S, Wahner-Roedler DL, Torkelson CJ, Cha SS, Thicke LS, Hazelton JH, et al. Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study. Altern Med Rev. 2010;15(1):59–67.
Goss P, Li T, Theriault M, Pinto S, Thompson L. Effects of dietary flaxseed in women with cyclical mastalgia [Abstract]. Breast Cancer Res Treat. 2000;64(1):49.
Speroff L, Rowan J, Symons J, Genant H, Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. JAMA. 1996;276(17):1397–403.
Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson G, et al. Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials. Breast Cancer Res Treat. 2012;132(1):275–85.
Coney P, Washenik K, Langley RG, DiGiovanna JJ, Harrison DD. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception. 2001;63(6):297–302.
Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study. J Am Coll Surg. 1997;184(6):596–604.
Mansel RE, Wisbey JR, Hughes LE. Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet. 1982;1(8278):928–30.
Ramsey-Stewart G. The treatment of symptomatic benign breast disease with danazol. Aust N Z J Obstet Gynaecol. 1988;28(4):299–304.
Watts JF, Butt WR, Logan Edwards R. A clinical trial using danazol for the treatment of premenstrual tension. Br J Obstet Gynaecol. 1987;94(1):30–4.
O’Brien PM, Abukhalil IE. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol. 1999;180(1 Pt 1):18–23.
Gorins A, Perret F, Tournant B, Rogier C, Lipszyc J. A French double-blind crossover study (danazol versus placebo) in the treatment of severe fibrocystic breast disease. Eur J Gynaecol Oncol. 1984;5(2):85–9.
Sutton GL, O’Malley VP. Treatment of cyclical mastalgia with low dose short term danazol. Br J Clin Pract. 1986;40(2):68–70.
Peters F, Reck G, Zimmermann G, Breckwoldt M. The effect of danazol on the pituitary function, thyroid function, and mastodynia. Arch Gynecol. 1980;230(1):3–8.
Baker HW, Snedecor PA. Clinical trial of danazol for benign breast disease. Am Surg. 1979;45(11):727–9.
Greenblatt B, Ben-Nun I. Danazol in the treatment of mammary dysplasia. Drugs. 1980;19(5):349–55.
Doberl A, Tobiassen T, Rasmussen T. Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. A double-blind placebo-controlled study–the Hjorring project. Acta Obstet Gynecol Scand Suppl. 1984;123:177–84.
Tobiassen T, Rasmussen T, Doberl A, Rannevik G. Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up–the Hjorring project. Acta Obstet Gynecol Scand Suppl. 1984;123:159–76.
Maddox PR, Harrison BJ, Mansel RE. Low-dose danazol for mastalgia. Br J Clin Pract Suppl. 1989;68:43–7; discussion 9–53.
Harrison BJ, Maddox PR, Mansel RE. Maintenance therapy of cyclical mastalgia using low-dose danazol. J R Coll Surg Edinb. 1989;34(2):79–81.
Ouimet-Oliva D, Van Campenhout J, Hebert G, Ladouceur J. Effect of danazol on the radiographic density of breast parenchyma. J Can Assoc Radiol. 1981;32(3):159–61.
Kaleli S, Aydin Y, Erel CT, Colgar U. Symptomatic treatment of premenstrual mastalgia in premenopausal women with lisuride maleate: a double-blind placebo-controlled randomized study. Fertil Steril. 2001;75(4):718–23.
Ioannidou-Mouzaka L, Niagassas M, Galanos A, Kalovidouris A. Pilot study on the treatment of cyclical mastodynia with Quinagolide. Eur J Gynaecol Oncol. 1999;20(2):117–21.
Kumar S, Mansel RE, Scanlon MF, Hughes LE, Edwards CA, Woodhead JS, et al. Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia. Br J Surg. 1984;71(11):870–3.
Kumar S, Mansel RE, Hughes LE, Woodhead JS, Edwards CA, Scanlon MF, et al. Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer. 1984;53(6):1311–5.
Mansel RE, Dogliotti L. European multicentre trial of bromocriptine in cyclical mastalgia. Lancet. 1990;335(8683):190–3.
Fentiman IS, Caleffi M, Brame K, Chaudary MA, Hayward JL. Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet. 1986;1(8476):287–8.
Powles TJ, Ford HT, Gazet J-C. A randomised trial to compare tamoxifen with danazol for treatment of benign mammary dysplasia. Breast Dis (Senologia). 1987;1987(2):1–5.
Messinis IE, Lolis D. Treatment of premenstrual mastalgia with tamoxifen. Acta Obstet Gynecol Scand. 1988;67(4):307–9.
Fentiman IS, Caleffi M, Hamed H, Chaudary MA. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg. 1988;75(9):845–6.
GEMB Group (Grupo de Estudio de Mastopatias Benignas) Argentine. Tamoxifen therapy for cyclical mastalgia: dose randomised trial. Breast. 1997;5:212–3.
Sandrucci S, Mussa A, Festa V. Comparison of tamoxifen and bromocriptine in management of fibrocystic breast disease: a randomized blind study. Ann N Y Acad Sci. 1990;586:626–8.
Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. Gynecol Endocrinol. 1997;11(6):393–7.
Hamed H, Caleffi M, Chaudary MA, Fentiman IS. LHRH analogue for treatment of recurrent and refractory mastalgia. Ann R Coll Surg Engl. 1990;72(4):221–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Files, J.A., Allen, S.V., Pruthi, S. (2015). Management of Breast Pain. In: Riker, A. (eds) Breast Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1145-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1145-5_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1144-8
Online ISBN: 978-1-4939-1145-5
eBook Packages: MedicineMedicine (R0)